Skip to main content
VCbacked
Log inGet Started

Phenomix Sciences

Rochester, United States

Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.

$2.5M raised
Dec 2025
Venture - Series Unknown
BiotechnologyHealth CareLife Science

Top Investors

LabCorpDexcomNational Institutes of HealthHealth2047Securian Financial Group

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Phenomix Sciences

How much funding has Phenomix Sciences raised?
Phenomix Sciences has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Who are Phenomix Sciences's investors?
Phenomix Sciences's investors include LabCorp, Dexcom, National Institutes of Health, Health2047, Securian Financial Group.
Where is Phenomix Sciences headquartered?
Phenomix Sciences is headquartered in Rochester, United States.
What does Phenomix Sciences do?
Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.
What stage is Phenomix Sciences at?
Phenomix Sciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Phenomix Sciences — Funding & Investors." VCBacked, December 29, 2025, https://www.vcbacked.co/company/phenomix-sciences. Accessed June 4, 2026.
APA
VCBacked. (2025). Phenomix Sciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/phenomix-sciences
Wikipedia (cite web)
{{cite web |title=Phenomix Sciences — Funding & Investors |url=https://www.vcbacked.co/company/phenomix-sciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong